products

Paclitaxel CAS 33069-62-4 Pharmaceutical Grade Chemicals C47H51NO14 For Ovarian Cancer

Basic Information
Place of Origin: CHINA
Brand Name: MOSINTER
Certification: COA
Model Number: Antineoplastic Drugs API - 22
Minimum Order Quantity: 1KG
Price: Negotiation
Packaging Details: Aluminum foil bag,kraft paper bag
Delivery Time: Within 7 days
Payment Terms: L/C, T/T
Supply Ability: Can be customized according to customer requirements
Detail Information
Name: Paclitaxel CAS: 33069-62-4
Form: Powder Molecular Formula: C47H51NO14
Molecular Weight: 853.91 Usage: Pharmaceutical Grade Chemicals
High Light:

chemical raw materials

,

pharmaceutical raw materials


Product Description

Paclitaxel CAS 33069-62-4 Pharmaceutical Grade Chemicals

 

Description:

 

Taxol is a monomer diterpenoids extracted from the bark of Taxus, a natural plant. It is a complex secondary metabolite and the only drug known to promote microtubule polymerization and stabilize the polymerized microtubules.

 

Specifications:

 

Tests Standards Results
Appearance white powder Wcrystalline powder.hite,
Identification A:IR absorption Complies Complies
B:UV absorption Complies Complies
C:TLC Complies Complies
Melting point 168~172°C 169.0~170.9°C
Water Not more than0.5% 0.08%
Related substance ImpurityJ(chloroacetanilide)not more than 10 ppm 2ppm
Impurity K(4-aminophenol)not more than 50 ppm 15 ppm
Impurity F(4-nitrophenol)not more than 0.05% Not detected
any other impurity not more than 0.05% 0.01%
Total of other impurities not more than 0.1% 0.02%
Residue on ignition Not more than 0.1% 0.05%
Chloride Not more than 0.014% Less than 0.014%
Sulfate Not more than 0.02% Less than 0.02%
Sulfide Conforms Conforms
Heavy metals Not more than 0.001% Less than 0.001%
Free p-aminophenol Not more than 0.005% Less than 0.005%
Limit of P-chloroacetanilide Not more than 0.001% Less than 0.001%
Readily carbonizable substances Conforms Conforms
Residual solvents

Residual content of acetic acid is limited

by the test of loss on dryingnot more than0.5%

0.08%
Assay(anhydrous basis) 99.0~101.0% 99.6%
Conclusion: Complies with USP34/ BP2011

 

Application:

 

1. Broad-spectrum anti-cancer botanical drugs for ovarian cancer, breast cancer, etc.

2. Broad-spectrum anti-cancer botanical drugs for the treatment of ovarian cancer, breast cancer and other diseases

3. Antineoplastic drugs. For the treatment of metastatic breast cancer and ovarian cancer. Broad-spectrum anti-cancer botanical drugs for the treatment of ovarian cancer, breast cancer and other diseases

4. Effective anti-cancer drugs; combined with the N-terminal region of beta-tubulin, promote highly stable microtubule-forming bodies, resist depolymerization, prevent normal cell division and capture in G2/M phase of cell cycle.

 

Our strengths:

 

We can customize according to customer's requirement.

If you have any question pls mail us or call us.

 

 

Contact Details
Fedor

Phone Number : +86 18989305995

WhatsApp : +18989305995